Advertisement

Corticosteroids in Ophthalmology

  • U. Pleyer
  • Z. Sherif
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 40)

Abstract

Few drugs have gained comparable importance, in almost any field of medical therapy, to corticosteroids. For the ophthalmologist, corticosteroids remain one of the basic therapeutics in a broad spectrum of inflammatory conditions. This review is intended to summarize some relevant aspects on the use of corticosteroids, their main indications, as well as their limitations in ophthalmology.

Keywords

Cystoid Macular Edema Allergic Conjunctivitis Fluocinolone Acetonide Posterior Subcapsular Cataract Prednisolone Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Armaly MF (1966) The heritable nature of dexamethasone-induced ocular hypertension. Arch Ophthalmol 75: 32 - 35PubMedCrossRefGoogle Scholar
  2. Barnes PJ, Adcock I (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 172: 436 - 441CrossRefGoogle Scholar
  3. Bettmann JW, Fund WE, Webster RG, Noyes PP, Vincent NJ (1967) Cataracto- genic effect of corticosteroids on animals. Am J Ophthalmol 63: 841 - 844Google Scholar
  4. Black RL, Oglesby RB, von Sallman L, et al (1960) Posterior subcapsular cataracts induced by corticoids in patients with rheumatoid arthritis. JAMA 174: 166 - 171PubMedCrossRefGoogle Scholar
  5. Blake EM, Fasanella RM, Wong AS (1950) The effect of ACTH in glaucoma. Am J Ophthalmol 33: 1231 - 1235PubMedGoogle Scholar
  6. Bodor B (1994) Designing softer ophthalmic drugs by soft drug approaches. J Ocul Pharmacol Ther 10: 3 - 15CrossRefGoogle Scholar
  7. Carnahan MC, Goldstein DA (2000) Ocular complications of topical, peri-ocu-lar and systemic corticosteroids. Curr Opin Ophthalmol 11: 478 - 483PubMedCrossRefGoogle Scholar
  8. Chylack LT (1997) Cataracts and inhaled corticosteroids. N Engl J Med 337: 46 - 48PubMedCrossRefGoogle Scholar
  9. Derby L, Maier WC (2000) Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol 105: 912 - 916PubMedCrossRefGoogle Scholar
  10. Dick AD (1999) Immune regulation of uveoretinal inflammation. In: Pleyer U, Zierhut M, Behrens-Baumann W (eds) Immuno-ophthalmology. S. Karger AG, Basel, pp 187 - 203CrossRefGoogle Scholar
  11. Elkinton JR, Hunt AD Jr, Godfrey L, McCory WW, Stokes J Jr (1949) Effects of pituitary adrenocorticotropic hormone ( ACTH) therapy. JAMA 141: 1273-1279Google Scholar
  12. Foreman AR, Loreto JA, Tina LV (1977) Reversibility of corticosteroid-associated cataracts in children with the nephrotic syndrome. Am J Ophthalmol 84: 75 - 78Google Scholar
  13. Friedberg M, Pleyer U, Mondino BJ (1991) Device drug delivery: collagen shields, iontophoresis, pumps. Ophthalmology 98: 725 - 732PubMedGoogle Scholar
  14. Garbe E, Suissa S, LeLorier J (1998) Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 280: 539 - 543PubMedCrossRefGoogle Scholar
  15. Hanania NA, Chapman KR, Kesten S (1995) Adverse effects of inhaled corticosteroids. Am J Med 98: 196 - 208PubMedCrossRefGoogle Scholar
  16. Howes JF (2000) Loteprednol etabonate: a review of ophthalmic clinical studies. Pharmazie 55: 178 - 183PubMedGoogle Scholar
  17. Hull DS, Hine JE, Edelhauser HF, Hyndius RA (1974) Permeability of the isolated rabbit cornea to corticosteroids. Invest Ophthalmol Vis Sci 13: 457 - 459Google Scholar
  18. Jaffe GJ, Yang CH, Guo H, Denny JP, Lima C, Ashton P (2000) Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Inv Ophthalmol Vis Sci 41: 3569 - 3575Google Scholar
  19. Johnson D, Gottanka J, Flugel C, Hoffmann F, Futa R, Lutjen Drecoll E (1997) Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol 115: 375 - 383PubMedCrossRefGoogle Scholar
  20. Kaplan HL (1984) Intermediate uveitis (pars planitis, chronic cyclitis): a four-step approach to treatment. In: Saari KM (ed) Uveitis update. Exerpta Medica 1984, Amsterdam, pp 169 - 172Google Scholar
  21. Leibowitz HM, Bartlett JD, Rich R, McQuirter H, Stewart R, Assil K (1996) Intraocular pressure-raising potential of 1% rimexolone in patients responding to corticosteroids. Arch Ophthalmol 114: 933 - 937PubMedCrossRefGoogle Scholar
  22. Leibowitz HM, Kupferman A (1976) Kinetics of topically administered prednisolone acetate. Arch Ophthalmol 94: 1387 - 1389PubMedCrossRefGoogle Scholar
  23. Mann WA, Markson DE (1950) A case of recurrent iritis and episcleritis on a rheumatic basis treated with ACTH. Am J Ophthalmol 33: 459 - 461Google Scholar
  24. McLean JM (1950) Clinical and experimental observation on the use of ACTH and cortisone in ocular inflammatory disease. Trans Am Ophthalmol Soc 48: 259Google Scholar
  25. Milani JK, Verbukh I, Pleyer U, Sumner H, Adamu SA, Halabi Hi, Chou HI, Lee DA, Mondino BJ (1993) Collagen shields impregnated with gentamycin-dexamethasone combination as a potential drug delivery device. Am J Ophthalmol 116: 622 - 627PubMedGoogle Scholar
  26. Mitchell P, Cumming RG, Mackey DA (1999) Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 106: 2301 - 2306PubMedCrossRefGoogle Scholar
  27. Novack GD, Howes J, Crockett RS, Sherwood MB (1998) Change in intraocular pressure during long-term use of loteprednol etabonate. J Glaucoma 7: 266 - 269PubMedGoogle Scholar
  28. Olson JA, Steffensen EH, Margulis RR, Smith RW, Whitney EL (1950) Effect of ACTH on certain inflammatory diseases of the eye. JAMA 142: 1276 - 1278CrossRefGoogle Scholar
  29. Ozerdem U, Levi L, Cheng L, Song MK, Scher C, Freeman WR (2000) Systemic toxicity of topical and periocular corticosteroid therapy in an 11-yearold male with posterior uveitis. Am J Ophthalmol 130: 240 - 241PubMedCrossRefGoogle Scholar
  30. Pleyer U, Lutz S, Jusko WJ, Nguyen K, Narawane M, Rückert D, Mondino BJ, Lee VHL (1993) Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. Invest Ophthalmol Vis Sci 34: 2737 - 2742PubMedGoogle Scholar
  31. Pleyer U, Elkins B, Rückert D, Lutz S, Grammer J, Chou J, Schmidt KH, Mondino BJ (1994) Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields. Curr Eye Res 13: 177 - 181PubMedCrossRefGoogle Scholar
  32. Pleyer U, Rieck P, Ritter T, Hartmann C (1998) Immunreaktion nach perforierender Keratoplastik. Ophthalmologe 95: 444 - 459PubMedCrossRefGoogle Scholar
  33. Pleyer U, Liekfeld A, Baatz H, Hartmann C (1999) Pharmakologische Modulation immunmediierter Erkrankungen des Auges. Klin Monatsbl Augenheilkd 214: 160 - 170PubMedCrossRefGoogle Scholar
  34. Polansky JR, Fauss DJ, Zimmerman CC (2000) Regulation of TIGR/MYOC gene expression in human trabecular meshwork cells. Eye 14: 503 - 514PubMedCrossRefGoogle Scholar
  35. Rauz S, Walker EA, Shackleton CH, Hewison M, Murray PI, Stewart PM (2001) Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye. Invest Ophthalmol Vis Sci 42: 2037 - 2042PubMedGoogle Scholar
  36. Southern AL, Altman K, Vittek J, Boniuk V, Gordon GG (1976) Steroid metabolism in ocular tissues of the rabbit. Invest Ophthalmol Vis Sci 15: 222 - 228Google Scholar
  37. Southern AL, Gordon GG, Yeh HS, Dunn MW, Weinstein BI (1977) Receptors for glucocorticoids in the lens epithelium of the calf. Science 200: 1177 - 1178CrossRefGoogle Scholar
  38. Stern JJ (1953) Acute glaucoma during cortisone therapy. Am J Ophthalmol 36: 389 - 390PubMedGoogle Scholar
  39. Stone EM, Tingert JH, Wallace LM, Nguyen TD, Polansky JR, Sheffield VC (1997) Identification of a gene that causes primary open-angle glaucoma. Science 275: 668 - 670PubMedCrossRefGoogle Scholar
  40. Sugar J, Burde RM, Sugar A, Waltman SR, Kripalani KJ, Weliky I, Becker B (1972) Tetrahydrotriamcinolone and triamcinolone I. Ocular penetration. Invest Ophthalmol Vis Sci 11: 890-893Google Scholar
  41. Tamada Y, Miyashita H, Ono S (1980) Studies on phospholipid metabolism of rabbit lens with special references to long-term topical administration of steroid. Jap J Ophthalmol 24: 289 - 296Google Scholar
  42. Urban RC Jr, Cotlier E (1986) Corticosteroid-induced cataracts. Sury Ophthalmol 31: 102 - 110CrossRefGoogle Scholar
  43. Watson D, Noble MJ, Dutton GN, Midgley JM, Healey TM (1988) Penetration of topically applied dexamethasone alcohol into human aqueous humor. Arch Ophthalmol 106: 686 - 687PubMedCrossRefGoogle Scholar
  44. Weiner A, BenEzra D (1991) Clinical patterns and associated conditions in chronic uveitis. Am J Ophthalmol 112: 151 - 158PubMedGoogle Scholar
  45. Woods AC (1950) Clinical and experimental observations on the use of ACTH and cortisone in ocular inflammatory disease. Am J Ophthalmol 33: 1325 - 1349PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • U. Pleyer
  • Z. Sherif

There are no affiliations available

Personalised recommendations